Runben Biotechnology Co Assets per Share
Total Assets per Share of Runben Biotechnology Co (603193.SS) as of Oct 25, 2026.
Get this data via API
Financial Data API
Assets per Share
0.00CNY
Last updated:
Total Assets per Share of Runben Biotechnology Co is 2025 0.00 CNY. Total Assets per Share of Runben Biotechnology Co was 2024 0.14 CNY. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Runben Biotechnology Co Stock analysis
What does Runben Biotechnology Co do? Runben Biotechnology Co., Ltd. generates revenue through the research, development, manufacture, and sale of mosquito repellent, baby care, and personal care products. The company's main product categories include electric mosquito repellent liquid, DEET mosquito repellent liquid, lipstick, face cream, facial cleanser, and skin care cream, which are sold via online direct sales, online platform distribution, and online platform agency sales. These products target domestic consumers in China, with the firm focusing on internet-based sales channels to reach its customer base.
The company's product portfolio spans mosquito repellent solutions, baby care items, and essential oil products, with key offerings such as DEET mosquito repellent liquid and electric mosquito repellent liquid driving sales. Baby care products and personal care items like lipstick and face cream are distributed through online platforms, leveraging digital channels to serve the domestic market. Runben Biotechnology emphasizes direct consumer engagement through e-commerce platforms to facilitate product distribution.
Runben Biotechnology's revenue streams are derived from the sale of its core product lines, including mosquito repellent products, baby care products, and essential oil products. The firm's domestic market focus ensures that its products, such as facial cleanser and skin care cream, are tailored to local consumer preferences. Online sales models, including direct online sales and platform agency sales, form the primary channel for product delivery to end-users. Runben Biotechnology Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Runben Biotechnology Co stock
On Eulerpool you can find the complete historical development of Total Assets per Share Runben Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.
Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Other — Runben Biotechnology Co
All Key Metrics — Runben Biotechnology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth